At the same time, FTO demethylates ALDOA transcripts, stabilizing them and promoting their persistence, ultimately leading to the metabolic adaptation of cancer cells to hypoxia, enhancing glycolysis and hepatocellular carcinoma (HCC) progression (Niu et al. 2021). The gene discussed is FTO; the disease is hepatocellular carcinoma.